Home / Health / New Prostate Cancer Treatment Preserves Quality of Life
New Prostate Cancer Treatment Preserves Quality of Life
13 Aug
Summary
- Organ-preserving focal HIFU targets only cancer, sparing healthy tissue.
- Minimally invasive approach reduces side effects and speeds recovery.
- Leading Indian hospitals integrate HIFU into cancer care programs.
Focal HIFU, a precision organ-preserving treatment, utilizes focused ultrasound to target only cancerous prostate cells, unlike whole-gland removal. This minimally invasive technique aims to significantly reduce urinary incontinence, preserve erectile function, and expedite recovery. International evidence supporting this therapy is growing, making it a vital component of multidisciplinary prostate cancer care.
Successful focal therapy relies on combining advanced technology with physician expertise, precise imaging interpretation, and individualized treatment strategies. Platforms like Sonablate® HIFU enable physicians to personalize care based on patient anatomy and disease characteristics. Several prominent Indian institutions, including Rajiv Gandhi Cancer Institute and Tata Memorial Hospital, have integrated HIFU into their programs.
Dr. Sudhir Rawal highlights the shift towards organ-preserving focal therapy as a major advancement, emphasizing that optimal outcomes depend on meticulous patient selection, high-quality imaging, and experienced clinical teams. This evolving approach prioritizes preserving patients' quality of life while achieving effective oncological results, offering renewed hope for localized prostate cancer patients in India.
